The International Oncology Leadership Conference brings together oncology administration leadership from all around the world to discuss best practices and current topics in the field:

  • Innovations in Technology

  • Personalized Medicine

  • Innovations in Staffing

  • Regulatory Structures and Issues

  • Data Acquisitions

  • Global Health Populations

  • Cost of Care

  • and more...

We are very pleased to be partnering with University College London Hospitals NHS Foundation Trust (UCLH) for the first IOLC.

About UCLH

Situated in the heart of London, University College London Hospitals NHS Foundation Trust (UCLH) provides first class acute and specialist services from five hospitals – University College Hospital (including the Macmillan Cancer Centre, Elizabeth Garrett Anderson Wing, Hospital for Tropical Diseases and the Institute of Sport, Exercise and Health), Royal National Throat, Nose and Ear Hospital, Royal London Hospital for Integrated Medicine, National Hospital for Neurology and Neurosurgery and the Eastman Dental Hospital.  We have close academic and research links to UCL, one of the world’s top ranking universities.

Cancer at UCLH

UCLH is a regional specialist centre for the treatment of many types of cancer including blood, brain, gynaecological, head and neck, lung, oesophago-gastric, paediatric, paediatric, penile, prostate and bladder, sarcoma and teenage and young adults.  In 2016 our expert teams treated 25,000 patients from our state-of-the-art facilities which include the Macmillan Cancer Centre which opened in 2012.  We are currently building a new facility to provide proton beam therapy and will be one of only two centres in the UK to offer this advanced form of radiotherapy.

Our research portfolio is extensive – in 2016 we recruited 1,725 patients and are currently running 31 immunotherapy trials, more than any other centre in Europe.  Many of our staff work at both UCL and UCLH and this, together with our close location to the prestigious UCL Cancer Institute, means that we’re able to translate research findings into breakthrough treatments.

In 2015, we were selected, with two other leading cancer providers, to become the national Cancer Vanguard.   Our challenge is to create new models of care that can be replicated across the UK. 

For more information about UCLH cancer, go to our website and read our regularly updated blog.